P
Paloma Health
The first digital medical practice helping hypothyroid patients better manage and treat their chronic condition
About Paloma Health
Paloma Health operates as a specialized telehealth company with a concentrated focus on treating hypothyroidism, a condition affecting an estimated 25 million Americans. The company was established in 2018 by co-founders Guillaume Cohen-Skalli (CEO) and Marina Tarasova (COO) after they identified a significant gap in patient care. They observed that individuals with hypothyroidism were often underserved due to long wait times for specialist appointments and a lack of comprehensive care.
The founders' professional backgrounds are complementary; Cohen-Skalli is a two-time founder with a history in venture capital, while Tarasova possesses extensive experience in sales and marketing within the pharmaceutical and biotech sectors. This blend of entrepreneurial and industry-specific expertise underpins the company's strategic direction. The initial mission was to create an accessible, end-to-end virtual clinic that addresses the multifaceted needs of thyroid patients from the convenience of their homes.
The core of Paloma Health's offering is a 'full-stack' virtual clinic model. This integrated approach provides patients with at-home thyroid blood test kits, online consultations with thyroid specialists and nutritionists, personalized medical guidance, and prescription management. Beyond standard medical treatment, the platform emphasizes a holistic methodology, incorporating diet and lifestyle guidance, nutritional supplements, and educational resources to address the root causes of the condition, such as Hashimoto's disease. The business generates revenue through a membership program, which provides ongoing access to care, as well as through the sale of at-home test kits and add-on biomarkers. The company also partners with health systems to expand its reach and provide in-network insurance coverage.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AEquity / VC | Jan 2023 | $0 | — | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Jul 2022 | $14M | $55M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Paloma Health is 250K monthly website visits, up 8.7% over the last three months. Paloma Health's team declined 4.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Paloma Health in the New York City ecosystem
The Paloma Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
TheVentureCity
Other known investors9 additional known investors
Aera VC
FJ Labs
Human Ventures
Kima Ventures
Nucleate
Red & Blue Ventures
s16vc
SpringTide
SWS Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Paloma Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Paloma Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










